U.S. IT Stock News

Wondering if MDU Resources Group at around US$19.65 is offering value right now, or if the recent run puts it on the expensive side. The stock has pulled back about 4.7% over the past week and 2.9% over the past month, although the 1 year return sits at 18.7% and the 3 and 5 year returns are 91.5% and 89.5% respectively. Recent coverage has focused on MDU Resources Group as a regulated utility and infrastructure business. Investors are paying attention to how its mix of operations and...

EMCOR Group (NYSE:EME) has been added to the FTSE All-World Index. This index inclusion is effective with the latest rebalance of FTSE Russell global benchmarks. The move may draw additional attention from institutional and index tracking investors. For EMCOR Group, trading at $724.93, inclusion in a global benchmark index comes after a very large 5 year return and a 76.0% return over the past year. Even with a 10.8% decline over the past 30 days and a 0.2% decline over the past week, the...

If you are asking whether Sunoco shares are still reasonably priced after a strong run, the answer depends on how you look at value and which metrics you trust most. With the stock at US$64.73, recent returns have been mixed, including a 0.4% decline over the last 7 days, a 3.5% gain over 30 days, 22.8% year to date, 21.4% over 1 year, 85.4% over 3 years, and 184.2% over 5 years. Investor attention has been shaped by ongoing coverage of Sunoco's role in the US energy sector, including...

Why Syndax Pharmaceuticals (SNDX) Is Drawing Investor Attention Now Syndax Pharmaceuticals (SNDX) has been catching investor interest after recent trading, with the stock last closing at US$24.23 and recent returns over the month and past 3 months standing out in the biotech space. See our latest analysis for Syndax Pharmaceuticals. For context, Syndax Pharmaceuticals has a 30 day share price return of 23.06% and a year to date share price return of 13.76%, while the 1 year total shareholder...

Investors may be wondering if Astera Labs at around US$116 per share still offers value after a big run, or if they might be late to the story. The stock is up 63.2% over the last year, although the 7 day, 30 day and year to date returns of 3.5%, 10.5% and 35.4% declines show that enthusiasm has cooled recently. Recent coverage has focused on Astera Labs as a key player in semiconductor infrastructure and AI related hardware. This helps explain why the share price has attracted attention...

Earlier in March 2026, Ambarella outlined its expanding Edge AI strategy at the Cantor Fitzgerald Global Technology and Industrial Growth Conference, revealing that Edge AI now contributes 80% of revenue and grew 50% over the prior year while also launching indirect sales channels and a semi-custom chip program targeting a future two-nanometer design. This shift toward a higher-mix Edge AI portfolio, coupled with plans for advanced semi-custom chips, marks a meaningful evolution in how...

Why International Seaways is on investors’ radar International Seaways (INSW) has drawn fresh attention after recent trading, with the share price around $67.75 and total return over the past 3 months and year highlighting how tanker exposure has recently played out for holders. See our latest analysis for International Seaways. The recent 1 day share price return of a 5.3% decline contrasts with a 41.5% 3 month share price gain and a very large 5 year total shareholder return. This suggests...

Franklin Resources, Inc. was recently removed from the FTSE All-World Index (USD), a move that may trigger portfolio rebalancing among index-tracking funds and institutional investors. This index exclusion puts a spotlight on how much of Franklin Resources’ investor base relies on benchmark-linked capital versus active, discretionary ownership. We’ll now examine how Franklin Resources’ removal from the FTSE All-World Index could reshape its investment narrative and future capital...

Aon plc recently announced past leadership changes effective March 2026, including appointing Anne Corona as CEO of North America, elevating Lori Goltermann to Vice Chair, and naming Farheen Dam as CEO of Enterprise Clients and Chief Client Officer, alongside several client-focused innovation initiatives spanning healthcare risk, delegated authority technology, and stablecoin premium settlements. Together, these leadership moves and client partnerships highlight how Aon is applying its risk,...

In March 2026, Darden Restaurants reported third-quarter sales of US$3,345.3 million, up from US$3,158.0 million a year earlier, while net income eased to US$306.8 million from US$323.4 million and earnings per share edged lower. Alongside this, the company raised its fiscal 2026 outlook with expected total sales growth of about 9.5% and same-restaurant sales growth of about 4.5%, signaling confidence in its brands’ ability to grow traffic and spend despite mixed profit trends. We’ll now...

Firefly Aerospace (FLY) is back on investors radar after reporting Q4 and full year 2025 results, issuing new 2026 revenue guidance of US$420 million to US$450 million, and completing the successful Alpha Flight 7 launch. See our latest analysis for Firefly Aerospace. Firefly Aerospace’s 16.22% 1 month share price return sits against an 18.81% 3 month share price decline and a modestly lower year to date share price. This suggests recent earnings, guidance and launch milestones are starting...

Mattel (MAT) is back in focus after unveiling a Barbie x CCM hockey collection with CCM Hockey, a product tie-up that extends the Barbie brand into performance sports gear while highlighting inclusivity and self expression. See our latest analysis for Mattel. Despite the renewed attention around Barbie and CCM Hockey, Mattel's share price return has weakened. A 30 day share price return of a 14.82% decline and a 1 year total shareholder return of a 25.10% decline suggest that momentum has...

Recent performance snapshot for Philip Morris International (PM) Philip Morris International (PM) has drawn investor attention after recent share price weakness, with a 7 day return of about a 7% decline and a one month return of roughly an 11% decline from its last close of $163.11. See our latest analysis for Philip Morris International. The recent 7-day and 30-day share price declines sit against a steadier picture, with a modestly positive year-to-date share price return and a stronger...

Why fresh concerns around Post Holdings (POST) are back in focus Recent bearish commentary on Post Holdings (POST) has zeroed in on declining U.S. cereal consumption, tougher competition from alternative breakfast options, and expectations of margin pressure and slower organic growth. See our latest analysis for Post Holdings. Post Holdings' recent share price weakness, including a 9.4% 1 month share price return and a 13.25% 1 year total shareholder return, suggests sentiment has cooled even...

Biogen (BIIB) is back in focus after Eisai and the company shared new real-world data at AD/PD 2026, showing that many patients remain on Alzheimer’s drug lecanemab beyond the initial 18-month treatment period. See our latest analysis for Biogen. Despite the positive lecanemab and pipeline headlines in recent weeks, Biogen’s share price has eased, with a 1-month share price return of a 5.5% decline and a 7-day return of a 1% decline, while the 1-year total shareholder return of 28.15%...

Why Brinker International (EAT) is Catching Investor Attention Now Brinker International (EAT) is back on many watchlists after recent share price weakness, with negative returns over the past week, month, past 3 months and year prompting fresh questions about valuation and earnings power. See our latest analysis for Brinker International. Despite the recent share price weakness, with the latest close at US$143.40 and a year to date share price decline of 5.36%, the three year total...

Mineralys Therapeutics, Inc. recently reported that its 2025 fourth-quarter net loss narrowed to US$32.23 million from US$48.95 million a year earlier, while the U.S. FDA accepted its New Drug Application for lorundrostat in adult hypertension with a PDUFA action date of December 22, 2026. The combination of reduced annual net loss to US$154.65 million and FDA review acceptance for lorundrostat marks a shift toward a more advanced, late-stage profile for Mineralys as it moves closer to a...

Alphabet (NasdaqGS:GOOGL) has rolled out an AI native overhaul of its Stitch design platform, introducing "vibe designing" and conversational UI creation tools. The update positions Stitch as a direct competitor to Figma and Adobe in collaborative design and prototyping for both designers and non designers. Alphabet has also finalized its acquisition of AI security platform Wiz, with plans to integrate it into Google Cloud offerings. For you as an investor, these moves sit at the...

Palantir Technologies (NasdaqGS:PLTR) is expanding its AI platforms into new real-world uses across aerospace, industrials, sports data, and financial services. Recent partnerships include multi-domain ISR work with Ondas and World View, AI transformation projects across LG Group, and nuclear fuel manufacturing optimization with Centrus Energy. The company is also building a next generation sports integrity platform with Polymarket, targeting fraud detection and market integrity in sports...

In March 2026, Ford Motor Company announced a long-term agreement with Bread Financial to launch a co-branded Ford Rewards Visa Signature credit card and integrated installment loan program, offering Points-based rewards and embedded financing for accessories, service, subscriptions and more across Ford’s online and dealership channels nationwide. By combining data-driven insights with Ford’s existing loyalty ecosystem, the partnership positions Bread Financial as a key enabler of more...

SS Innovations International, Inc. reported past 2025 results showing full-year revenue rising to US$42.48 million from US$20.65 million, while narrowing its net loss to US$12.13 million and disclosing auditor concerns about its ability to continue as a going concern. Separately, the company’s SSi Mantra surgical robotic system secured approval for telesurgeries in Indonesia and the Philippines and passed 150 cumulative telesurgeries, signaling expanding real-world use of its technology...

Vishay Intertechnology recently introduced the SGCM05339, a space-grade surface-mount common mode choke designed for EMI filtering and noise suppression in demanding space, aerospace, defense, power conversion, and solar applications, featuring a rugged nanocrystalline core, high current capability up to 14.43 A, and operation from -55 °C to +130 °C. By combining space-qualified screening options such as MIL-PRF-27 and MIL-STD-981 with customizable electrical characteristics, the SGCM05339...

If you are wondering whether Silicon Motion Technology's share price still makes sense after a strong run, the key question is how its current market price compares with a grounded estimate of value. The stock last closed at US$123.76, with returns of 0.4% over 7 days, an 8.2% decline over 30 days, and gains of 32.0% year to date and 127.5% over 1 year. Recent coverage has focused on Silicon Motion Technology as a semiconductor name that has attracted attention after its strong 1-year share...

Bausch + Lomb recently held a special call to discuss two glaucoma assets and deeper insights into its differentiated product pipeline, following the unveiling of this pipeline in November 2025. Alongside this, CEO and Chairman Brenton L. Saunders’ presentation at the Longwood Healthcare Leaders Miami conference highlighted management’s effort to spotlight innovation and future product opportunities to a healthcare-focused investor audience. We will now explore how the focused glaucoma call...